Search

everythinglearnresearchcommunity

for

Search:↓

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The conclusion is to thoroughly test for causes of cat hair loss and treat accordingly, considering medication only after serious conditions are ruled out.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Caffeine penetrates human skin in lab tests similarly to real-life conditions, but actual skin use is still essential for accurate results.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

The model and estimator can predict drug exposure in kidney transplant patients well.